332 related articles for article (PubMed ID: 14749503)
21. Obesity as a cardiovascular risk factor.
Sowers JR
Am J Med; 2003 Dec; 115 Suppl 8A():37S-41S. PubMed ID: 14678864
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and metabolic dichotomy in obesity: clinical, biochemical and immunological correlates of metabolically divergent obese phenotypes in healthy South Asian adults.
Khawaja KI; Mian SA; Fatima A; Tahir GM; Khan FF; Burney S; Hasan A; Masud F
Singapore Med J; 2018 Aug; 59(8):431-438. PubMed ID: 29430577
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria.
Kocełak P; Chudek J; Olszanecka-Glinianowicz M
Minerva Endocrinol; 2012 Sep; 37(3):247-54. PubMed ID: 22766891
[TBL] [Abstract][Full Text] [Related]
24. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
[TBL] [Abstract][Full Text] [Related]
25. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
Ferrannini E; Camastra S
Eur J Clin Invest; 1998 Sep; 28 Suppl 2():3-6; discussion 6-7. PubMed ID: 9777320
[TBL] [Abstract][Full Text] [Related]
26. Do differences in waist circumference modify the relationships among body mass index, insulin resistance, and related cardiometabolic risk factors in apparently healthy women?
Salazar MR; Carbajal HA; Espeche WG; Balbín E; Aizpurúa M; Marillet AG; Reaven GM
J Am Coll Nutr; 2014; 33(1):32-8. PubMed ID: 24533606
[TBL] [Abstract][Full Text] [Related]
27. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
l'Allemand-Jander D
Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
[TBL] [Abstract][Full Text] [Related]
28. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
[TBL] [Abstract][Full Text] [Related]
30. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
[TBL] [Abstract][Full Text] [Related]
31. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
[TBL] [Abstract][Full Text] [Related]
32. Exercise in weight management of obesity.
Poirier P; Després JP
Cardiol Clin; 2001 Aug; 19(3):459-70. PubMed ID: 11570117
[TBL] [Abstract][Full Text] [Related]
33. Changes in risk factors for cardiovascular disease with body fat loss in obese women.
Krebs JD; Evans S; Cooney L; Mishra GD; Fruhbeck G; Finer N; Jebb SA
Diabetes Obes Metab; 2002 Nov; 4(6):379-87. PubMed ID: 12406035
[TBL] [Abstract][Full Text] [Related]
34. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss.
Havel PJ; Kasim-Karakas S; Mueller W; Johnson PR; Gingerich RL; Stern JS
J Clin Endocrinol Metab; 1996 Dec; 81(12):4406-13. PubMed ID: 8954050
[TBL] [Abstract][Full Text] [Related]
35. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
36. Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity?
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Marillet AG; Leiva Sisnieguez CE; Leiva Sisnieguez BC; Stavile RN; March CE; Reaven GM
J Investig Med; 2017 Feb; 65(2):323-327. PubMed ID: 27638846
[TBL] [Abstract][Full Text] [Related]
37. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
[TBL] [Abstract][Full Text] [Related]
38. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
[TBL] [Abstract][Full Text] [Related]
39. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
